Reck M - Search Results

1

Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1-positive advanced non-small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies.

Nosaki K, Saka H, Hosomi Y, Baas P, de Castro G Jr, Reck M, Wu YL, Brahmer JR, Felip E, Sawada T, Noguchi K, Han SR, Piperdi B, Kush DA, Lopes G. Nosaki K, et al. Among authors: reck m. Lung Cancer. 2019 Sep;135:188-195. doi: 10.1016/j.lungcan.2019.07.004. Epub 2019 Jul 8. Lung Cancer. 2019. PMID: 31446994

2

Phase II and III studies with carboplatin in small cell lung cancer.

Gatzemeier U, Hossfeld DK, Neuhauss R, Reck M, Achterrath W, Lenaz L. Gatzemeier U, et al. Among authors: reck m. Semin Oncol. 1992 Feb;19(1 Suppl 2):28-36. Semin Oncol. 1992. PMID: 1329220 Clinical Trial.

3

Carboplatin in small cell lung cancer.

Gatzemeier U, Hossfeld DK, Neuhauss R, Reck M, Achterrath W, Lenaz L. Gatzemeier U, et al. Among authors: reck m. Semin Oncol. 1991 Feb;18(1 Suppl 2):8-16. Semin Oncol. 1991. PMID: 1846981 Clinical Trial.

4

Long-term survival in SCLC after treatment with paclitaxel, carboplatin and etoposide--a phase II study.

Reck M, Jagos U, Grunwald F, Kaukel E, Koschel G, von Pawel J, Hessler S, Gatzemeier U. Reck M, et al. Lung Cancer. 2003 Jan;39(1):63-9. doi: 10.1016/s0169-5002(02)00383-5. Lung Cancer. 2003. PMID: 12499096 Clinical Trial.

5

Chemotherapy in stage-IV NSCLC.

Reck M, Gatzemeier U. Reck M, et al. Lung Cancer. 2004 Aug;45 Suppl 2:S217-22. doi: 10.1016/j.lungcan.2004.07.972. Lung Cancer. 2004. PMID: 15552802 Review.

6

[Phase II-trial of tirapazamine in combination with cisplatin and gemcitabine in patients with advanced non-small-cell-lung-cancer (NSCLC)].

Reck M, von Pawel J, Nimmermann C, Groth G, Gatzemeier U. Reck M, et al. Pneumologie. 2004 Dec;58(12):845-9. doi: 10.1055/s-2004-830056. Pneumologie. 2004. PMID: 15597251 Clinical Trial. German.

7

Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen.

Reck M, Groth G, Buchholz E, Goetz E, Gatzemeier U, Manegold C. Reck M, et al. Lung Cancer. 2005 Jun;48(3):409-13. doi: 10.1016/j.lungcan.2004.11.013. Epub 2005 Jan 23. Lung Cancer. 2005. PMID: 15893010 Clinical Trial.

8

Benefit in lung function improvement and side-effect profile of long-term responders: an analysis of 14 NSCLC patients treated for at least 9 months with gefitinib.

Reck M, Gatzemeier U. Reck M, et al. Lung Cancer. 2005 Oct;50(1):107-14. doi: 10.1016/j.lungcan.2005.05.006. Lung Cancer. 2005. PMID: 15985306 Clinical Trial.

9

Current approaches in chemotherapy of advanced and metastatic non-small cell lung cancer (NSCLC).

Reck M. Reck M. Anticancer Res. 2005 May-Jun;25(3A):1501-6. Anticancer Res. 2005. PMID: 16033051 Free article. Review.

10

EGFR tyrosine kinase inhibitors in non-small cell lung cancer: report of a 3-year compassionate use experience with gefitinib in stage IIIB/IV outpatients.

Reck M, Gatzemeier U. Reck M, et al. Onkologie. 2005 Dec;28(12):623-7. doi: 10.1159/000088931. Epub 2005 Dec 1. Onkologie. 2005. PMID: 16330885

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

521 results

Search Page